Effect of combination therapy with angiotensin receptor blocker and 1,25-dihydroxyvitamin D(3) in type 2 diabetic nephropathy in KK-A(y)/Ta mice. (Q54642763)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Effect of combination therapy with angiotensin receptor blocker and 1,25-dihydroxyvitamin D(3) in type 2 diabetic nephropathy in KK-A(y)/Ta mice.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

2 June 2018

http://europepmc.org/abstract/MED/20948237

Effect of combination therapy with angiotensin receptor blocker and 1,25-dihydroxyvitamin D(3) in type 2 diabetic nephropathy in KK-A(y)/Ta mice. (English)

1 reference

Europe PubMed Central

2 June 2018

http://europepmc.org/abstract/MED/20948237

diabetic nephropathy

1 reference

based on heuristic

inferred from title

author name string

Ikko Ohara

1

1 reference

Europe PubMed Central

2 June 2018

http://europepmc.org/abstract/MED/20948237

Mitsuo Tanimoto

2

1 reference

Europe PubMed Central

2 June 2018

http://europepmc.org/abstract/MED/20948237

Tomohito Gohda

3

1 reference

Europe PubMed Central

2 June 2018

http://europepmc.org/abstract/MED/20948237

Takahiko Yamazaki

4

1 reference

Europe PubMed Central

2 June 2018

http://europepmc.org/abstract/MED/20948237

Shinji Hagiwara

5

1 reference

Europe PubMed Central

2 June 2018

http://europepmc.org/abstract/MED/20948237

Maki Murakoshi

6

1 reference

Europe PubMed Central

2 June 2018

http://europepmc.org/abstract/MED/20948237

Tatsuya Aoki

7

1 reference

Europe PubMed Central

2 June 2018

http://europepmc.org/abstract/MED/20948237

Hitoe Toyoda

8

1 reference

Europe PubMed Central

2 June 2018

http://europepmc.org/abstract/MED/20948237

Yuji Ishikawa

9

1 reference

Europe PubMed Central

2 June 2018

http://europepmc.org/abstract/MED/20948237

Kazuhiko Funabiki

10

1 reference

Europe PubMed Central

2 June 2018

http://europepmc.org/abstract/MED/20948237

Satoshi Horikoshi

11

1 reference

Europe PubMed Central

2 June 2018

http://europepmc.org/abstract/MED/20948237

Yasuhiko Tomino

12

1 reference

Europe PubMed Central

2 June 2018

http://europepmc.org/abstract/MED/20948237

publication date

13 October 2010

1 reference

Europe PubMed Central

2 June 2018

http://europepmc.org/abstract/MED/20948237

The Nephron Journals

1 reference

Europe PubMed Central

2 June 2018

http://europepmc.org/abstract/MED/20948237

117

1 reference

Europe PubMed Central

2 June 2018

http://europepmc.org/abstract/MED/20948237

4

1 reference

Europe PubMed Central

2 June 2018

http://europepmc.org/abstract/MED/20948237

e124-32

1 reference

Europe PubMed Central

2 June 2018

http://europepmc.org/abstract/MED/20948237

The renin-angiotensin-aldosterone system and the kidney: effects on kidney disease

1 reference

https://api.crossref.org/works/10.1159%2F000320284

21 January 2018

Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass

1 reference

https://api.crossref.org/works/10.1159%2F000320284

21 January 2018

Proinflammatory effects of angiotensin II and endothelin: targets for progression of cardiovascular and renal diseases

1 reference

https://api.crossref.org/works/10.1159%2F000320284

21 January 2018

Angiotensin II as a mediator of tubulointerstitial injury

1 reference

https://api.crossref.org/works/10.1159%2F000320284

21 January 2018

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

1 reference

https://api.crossref.org/works/10.1159%2F000320284

21 January 2018

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

1 reference

https://api.crossref.org/works/10.1159%2F000320284

21 January 2018

Direct renin inhibition with aliskiren in hypertension and target organ damage

1 reference

https://api.crossref.org/works/10.1159%2F000320284

21 January 2018

Renin increases mesangial cell transforming growth factor-beta1 and matrix proteins through receptor-mediated, angiotensin II-independent mechanisms

1 reference

https://api.crossref.org/works/10.1159%2F000320284

21 January 2018

Renin-stimulated TGF-beta1 expression is regulated by a mitogen-activated protein kinase in mesangial cells.

1 reference

https://api.crossref.org/works/10.1159%2F000320284

21 January 2018

Slowly progressive, angiotensin II-independent glomerulosclerosis in human (pro)renin receptor-transgenic rats

1 reference

https://api.crossref.org/works/10.1159%2F000320284

21 January 2018

1,25-Dihydroxyvitamin D3decreases podocyte loss and podocyte hypertrophy in the subtotally nephrectomized rat

1 reference

https://api.crossref.org/works/10.1159%2F000320284

21 January 2018

A vitamin D analog ameliorates glomerular injury on rat glomerulonephritis

1 reference

https://api.crossref.org/works/10.1159%2F000320284

21 January 2018

Effects of 1,25(OH)2D3 in experimental mesangial proliferative nephritis in rats.

1 reference

https://api.crossref.org/works/10.1159%2F000320284

21 January 2018

Effect of 1,25 (OH)2 vitamin D3 on glomerulosclerosis in subtotally nephrectomized rats

1 reference

https://api.crossref.org/works/10.1159%2F000320284

21 January 2018

1,25-dihydroxyvitamin D3 suppresses renin gene transcription by blocking the activity of the cyclic AMP response element in the renin gene promoter.

1 reference

https://api.crossref.org/works/10.1159%2F000320284

21 January 2018

Combination therapy with AT1 blocker and vitamin D analog markedly ameliorates diabetic nephropathy: blockade of compensatory renin increase

1 reference

https://api.crossref.org/works/10.1159%2F000320284

21 January 2018

Candesartan reduced advanced glycation end-products accumulation and diminished nitro-oxidative stress in type 2 diabetic KK/Ta mice

1 reference

https://api.crossref.org/works/10.1159%2F000320284

21 January 2018

Glomerular changes in the KK-Ay/Ta mouse: a possible model for human type 2 diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1159%2F000320284

21 January 2018

Diabetic nephropathy in KK and KK-Ay mice

1 reference

https://api.crossref.org/works/10.1159%2F000320284

21 January 2018

Role of growth hormone in the development of experimental renal scarring

1 reference

https://api.crossref.org/works/10.1159%2F000320284

21 January 2018

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

1 reference

https://api.crossref.org/works/10.1159%2F000320284

21 January 2018

Pivotal role of the renin/prorenin receptor in angiotensin II production and cellular responses to renin

1 reference

https://api.crossref.org/works/10.1159%2F000320284

21 January 2018

Differential effects of vitamin D analogs on vascular calcification

1 reference

https://api.crossref.org/works/10.1159%2F000320284

21 January 2018

Osteoprotegerin inhibits artery calcification induced by warfarin and by vitamin D.

1 reference

https://api.crossref.org/works/10.1159%2F000320284

21 January 2018

1,25-dihydroxyvitamin D inhibits renal interstitial myofibroblast activation by inducing hepatocyte growth factor expression

1 reference

https://api.crossref.org/works/10.1159%2F000320284

21 January 2018

Combination therapy with an angiotensin-converting enzyme inhibitor and a vitamin D analog suppresses the progression of renal insufficiency in uremic rats.

1 reference

https://api.crossref.org/works/10.1159%2F000320284

21 January 2018

Prevention of chronic allograft nephropathy with vitamin D.

1 reference

https://api.crossref.org/works/10.1159%2F000320284

21 January 2018

Aliskiren combined with losartan in type 2 diabetes and nephropathy

1 reference

https://api.crossref.org/works/10.1159%2F000320284

21 January 2018

Effectiveness of aldosterone blockade in patients with diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1159%2F000320284

21 January 2018

Aldosterone breakthrough caused by chronic blockage of angiotensin II type 1 receptors in human adrenocortical cells: possible involvement of bone morphogenetic protein-6 actions

1 reference

https://api.crossref.org/works/10.1159%2F000320284

21 January 2018

Albuminuria Is a Target for Renoprotective Therapy Independent from Blood Pressure in Patients with Type 2 Diabetic Nephropathy: Post Hoc Analysis from the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) Trial

1 reference

https://api.crossref.org/works/10.1159%2F000320284

21 January 2018

Identifiers

10.1159/000320284

1 reference

Europe PubMed Central

2 June 2018

http://europepmc.org/abstract/MED/20948237

1 reference

Europe PubMed Central

2 June 2018

http://europepmc.org/abstract/MED/20948237

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54642763&oldid=1516274481"